Sam Salama is a seasoned Biomedical Engineer with over a decade of diverse experience spanning domestic, regional, and international landscapes. Currently serving as a Senior Lab Automation Engineer in the Research and Development (R&D) team at GRAIL, Sam plays a pivotal role in the development...
Sam Salama is a seasoned Biomedical Engineer with over a decade of diverse experience spanning domestic, regional, and international landscapes. Currently serving as a Senior Lab Automation Engineer in the Research and Development (R&D) team at GRAIL, Sam plays a pivotal role in the development and construction of an innovative, fully automated platform for Multi-Cancer Early Detection through liquid biopsies. His expertise in product development, lab automation, and robotic systems positions him as a key contributor to projects that are at the forefront of cancer diagnostics.
In his current role, Sam is instrumental in building and validating a custom-made Plasma Isolation System, which is critical for enhancing the accuracy and efficiency of liquid biopsy processes. His hands-on experience with advanced liquid handling systems, including Tecan Fluent, Agilent Bravo, and Hamilton Star, allows him to script and optimize workflows that significantly improve throughput and reliability. Sam’s commitment to continuous improvement is evident in his work on hardware and software enhancements for highly automated robotic systems, ensuring that GRAIL remains a leader in the biotechnology field.
Sam’s proficiency in hardware diagnostics, GMP compliance, and value stream mapping further underscores his capability to drive projects from conception through to successful implementation. As a "train the trainer" advocate, he not only contributes to new product introductions but also provides ongoing support to ensure that on-market products meet the highest standards of quality and performance. His collaborative spirit and coaching skills foster a culture of innovation and excellence within his team, making him an invaluable asset in the quest to revolutionize cancer detection and improve patient outcomes.
